Discuss PSEN1 test results in a planned visit with a genetics counselor or memory specialist, with a trusted support person present. PSEN1 (presenilin 1) is a gene that affects brain-cell processing; certain harmful variants in it cause inherited early-onset Alzheimer disease.
Harmful PSEN1 variants often lead to symptoms in the 30s to 50s and are the most common of the three familial causes tied to APP, PSEN1, and PSEN2, according to the U.S. National Library of Medicine review in its 2012 familial Alzheimer genetics review. Guidelines call for counseling before and after testing to prepare for medical, family, and insurance effects.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What does a positive result mean?
- How should the results visit be arranged?
- What should you avoid predicting?
- What practical steps come next?
What does a positive result mean?
A positive result means the person carries a highly penetrant cause of early-onset Alzheimer disease type 3. It is inherited in an autosomal-dominant pattern, so a child inherits either the working or altered copy.
Each first-degree relative of a carrier faces a 50% inheritance risk. Penetrance is essentially complete by about age 60 to 65, so carriers are expected to develop disease, according to the same National Library of Medicine review.
How should the results visit be arranged?
Test an affected relative first when possible, rather than starting with a younger adult who has memory concerns but no diagnosis. Offer pre-test and post-test counseling with a trained genetics professional.
U.S. joint genetics guidelines recommend a careful disclosure process modeled on Huntington disease practice, with a support person present, as described by the American College of Medical Genetics and National Society of Genetic Counselors in their joint testing guidelines. Keep the setting private, allow time for questions, and pause when distress rises.
What should you avoid predicting?
Tell younger adults that a positive result confirms a strong cause but does not set a personal calendar. The specific gene change should not be used to predict exact onset age, symptom mix, severity, or speed of decline.
Predictive testing of an at-risk adult without symptoms is possible, but it has limited precision for prognosis. GeneReviews notes the same limit and urges counseling that covers offspring risk and reproductive options.
What practical steps come next?
Refer to a genetics counselor, cognitive neurologist, or memory clinic when testing is considered. That visit should review benefits and drawbacks, where results are stored, who can see them, family implications, and that a negative or uncertain result does not rule out all genetic causes, according to Alzheimer's Research UK in its genes and dementia guide.
Useful next actions include: Discuss insurance before blood is drawn. The University of Michigan Health Lab explains that the federal GINA law bars use of genetic results in health insurance and employment decisions but does not cover life, disability, or long-term-care insurance, in its guide to genetic discrimination protections.
- write down who should hear the result and when
- ask about follow-up brain care, support services, and research referrals
- discuss plans for children, pregnancy, and family testing
- review work leave, driving, safety, and daily support needs
You Might Also Like
- Can PSEN2 Genetic Test Change Dementia Care Decisions After New Memory Symptoms?
- PSEN2 Genetic Test During an Alzheimer’s Workup: What It Measures and What It Misses
- The Long-Term Care Data Cooperative and Dementia Research in 2026: Why the Findings May Not Change Care Yet for Adults With Memory Concerns
